Compounds > linsidomine
Page last updated: 2024-11-04

linsidomine and Hyperplasia

linsidomine has been researched along with Hyperplasia in 2 studies

linsidomine: RN given refers to parent cpd; structure

Hyperplasia: An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Harnek, J2
Zoucas, E2
de Sá, VP1
Ekblad, E2
Arner, A2
Stenram, U2
Sjuve, R1
Schou, H1
Perez de Sá, V1

Other Studies

2 other studies available for linsidomine and Hyperplasia

ArticleYear
Intimal hyperplasia in balloon dilated coronary arteries is reduced by local delivery of the NO donor, SIN-1 via a cGMP-dependent pathway.
    BMC cardiovascular disorders, 2011, Jun-11, Volume: 11

    Topics: Actins; Analysis of Variance; Angioplasty, Balloon, Coronary; Animals; Coronary Angiography; Coronar

2011
Local infusion of the nitric oxide donor Sin-1 after angioplasty. Effects on intimal hyperplasia in porcine coronary arteries.
    Acta radiologica (Stockholm, Sweden : 1987), 2003, Volume: 44, Issue:4

    Topics: Angioplasty, Balloon, Coronary; Animals; Coronary Restenosis; Coronary Vessels; Female; Hyperplasia;

2003